Folate therapy for prevention of cardiovascular risk in uremia
Perna, A.
Giornale Italiano di Nefrologia Organo Ufficiale Della Societa Italiana di Nefrologia 25(3): 273
2008
ISSN/ISBN: 0393-5590 PMID: 18473294 Document Number: 616919
Document emailed within 1 workday
Related Documents
Fabbian, F. 2008: Physical training in uremia: a healthy approach to cardiovascular risk Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 25(1): 7Osler, M.; Jespersen, N.B.; Lous, J.; Rasmussen, N.K. 1992: Cardiovascular risk factors--extent and self-assessed risk in relation to prevention of cardiovascular diseases. A questionnaire among 3,956 men and women aged 24-65 years in Vejle County, Slangerup and Helsinge municipalities Ugeskrift for Laeger 154(9): 538-543
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558
Chello, P.L.; McQueen, C.A.; DeAngelis, L.M.; Bertino, J.R. 1977: Comparative effects of folate antagonists versus enzymatic folate depletion on folate and thymidine enzymes in cultured mammalian cells Cancer Treatment Reports 61(4): 539-548
Ciammella, M.; Guareschi, B.; Pes, S.; Cocucci, C.; Nencioni, T. 1993: Substitution estrogen therapy in the prevention of postmenopausal osteoporosis and cardiovascular diseases. Results of long-term therapy Minerva Ginecologica 45(1-2): 53-55
Bongard, V.; Ferrières, J. 2006: Cardiovascular risk factors and prevention La Revue du Praticien 56(1): 79-87 94
Friedman, S.A.; Rosen, H. 1974: Uremia and cardiovascular mortality Annals of Internal Medicine 81(5): 696-697
Meister, W. 1989: Risk factors and prevention of cardiovascular diseases Der Internist 30(5): 276-282
Volpe, M.; Tocci, G. 2012: Global cardiovascular risk management in primary prevention Current Vascular Pharmacology 10(6): 709-711
Béliard-Lasserre, S. 2016: Should we prescribe statins for primary prevention of cardiovascular risk? Rather yes La Revue du Praticien 66(3): 332-334
Brohet, C. 1995: Risk factors and primary prevention of cardiovascular disease Journal de Pharmacie de Belgique 50(1): 20-24
McCarthy, M. 2013: New US prevention guidelines focus on overall risk of cardiovascular disease Bmj 347: F6858
Kannel, W.B. 1996: Blood pressure as a cardiovascular risk factor: prevention and treatment JAMA 275(20): 1571-1576
Laaser, U.; Allhoff, P. 1982: Prevention during adolescence: cardiovascular risk profile in juveniles of Cologne Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 130(10): 760-766
Marques-Vidal, P.; Bongard, V.; Arveiler, D.; Amouyel, P.; Ducimetière, P.; Ferrières, J. 2002: Medical cost of cardiovascular risk factors prevention in France Archives des Maladies du Coeur et des Vaisseaux 95(4): 275-281
Moulin, P.; Sérusclat, Aé.; Bernard, S. 2005: Cardiovascular prevention of high risk patients by hypolipidemic treatment La Revue du Praticien 55(16): 1783-1787
Richard, J.L.; Delahaye, F. 1998: Cardiovascular prevention, primary or secondary, in high risk patients Archives des Maladies du Coeur et des Vaisseaux 91(12): 1495-1502
Danchin, N. 2005: Cardiovascular risk factors: on which elements to base the actions of prevention? La Revue du Praticien 55(16): 1753-1754
1999: Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases: The Role of the Cardiovascular Specialist Canadian Journal of Cardiology 15 Suppl G: 1g
Henriquez, D.; Dikow, R.; Ritz, E. 2004: Cardiovascular disease in chronic renal failure. Risk factors and prevention Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 24 Suppl. 4: 34-39